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Epidemiological and biochemical studies show that the sporadic forms of Alzheimer’s
disease (AD) are characterized by the following hallmarks: (a) An exponential increase with
age; (b) Selective neuronal vulnerability; (c) Inverse cancer comorbidity. The present article
appeals to these hallmarks to evaluate and contrast two competing models of AD: the
amyloid hypothesis (a neuron-centric mechanism) and the Inverse Warburg hypothesis
(a neuron-astrocytic mechanism). We show that these three hallmarks of AD conflict
with the amyloid hypothesis, but are consistent with the Inverse Warburg hypothesis,
a bioenergetic model which postulates that AD is the result of a cascade of three
events—mitochondrial dysregulation, metabolic reprogramming (the Inverse Warburg
effect), and natural selection. We also provide an explanation for the failures of the
clinical trials based on amyloid immunization, and we propose a new class of therapeutic
strategies consistent with the neuroenergetic selection model.
Keywords: age-related disease, mitochondrial dysregulation, metabolic alteration, the Inverse Warburg effect,
inverse cancer comorbidity
INTRODUCTION
Epidemiological studies of the incidence of Alzheimer’s disease
(AD) distinguish between two classes of individuals with clin-
ical and histopathological features of the disorder—those with
an autosomal dominant inheritance—an early onset group; and
those with the sporadic form of the disease—a late onset group.
Investigators have observed genetic defects in individuals with
the familial forms of the disease. The genes implicated are the
amyloid precursor protein (APP), and the secretases, presenilin 1
and presenilin 2, enzymes involved with APP processing. Mutant
forms of these genes induce an overproduction of beta amy-
loid due to an alteration in APP processing, creating an imbal-
ance between production and clearance, and the clinical and
histopathological phenotype associated with AD. This correlation
between beta amyloid and the various histological and clinical
hallmarks of the disease is the basis for the Amyloid hypothesis as
a model for the familial forms of AD. The model, first proposed
by Glenner and Wong (1984), contends that the neurodegener-
ative disease is due to an imbalance between the generation and
clearance of beta amyloid.
The hypothesis of Glenner andWong was subsequently shown
to be consistent with certain molecular, biochemical and neu-
ropathological studies of sporadic forms of AD (Selkoe, 1991;
Hardy and Selkoe, 2002; Hardy, 2009). In parallel, the demon-
stration that the Aβ peptide exhibits neurotoxicity has led to the
development of an important area of research around this topic
as the main explanation for the etiology of the disease (Cavallucci
et al., 2012). Accordingly, the amyloid model emerged as the
organizing element in studies of both familial and sporadic forms
of AD.
The reviews by Bertram and Tanzi (2008) as well as Tanzi
and Bertram (2005) have elucidated the genetic origins for the
familial and the late onset forms of the disease. These articles
have documented and analyzed genes that are considered poten-
tial risk factors for AD. These studies, however, indicate that none
of the genes implicated in the familial form of AD consistently
influences disease risk in the late onset form. In the case of one
genetic variant, an allele of the apolipoprotein E gene (APOE)
called APOE4, it was shown that it represents a risk factor, but it
accounts for very little in the heritability of the disease and cannot
be considered as a cause of the early onset form of the disease.
Indeed, biochemical and epidemiological studies now indicate
that age is the dominant risk factor in sporadic forms of AD.
These investigations suggest that the amyloid plaques that are
considered the biochemical hallmarks of the disease are also con-
sistent with an age-related misfolding of the APP protein (Chiti
and Dobson, 2009). However, in spite of these studies, propo-
nents of the amyloid hypothesis have maintained that a mutation
induced overproduction of beta amyloid underlies both the early
onset and the late onset forms of AD, and consequently, both
forms of the disease can be ascribed similar etiologies (Hardy,
2009; Selkoe, 2012).
The extrapolation of the model of early onset forms of AD to
the late onset expressions is based on the assumption that age is
primarily a measure of how long it takes for neurons to accu-
mulate toxic moieties of beta amyloid. Accordingly, an imbalance
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between amyloid production and clearance can also be considered
as the primary cause of sporadic AD. This argument is the ratio-
nale for therapeutic strategies of late onset AD based on targeting
amyloid pathways, either through passive immunotherapy against
beta amyloid, or active inhibition of beta amyloid generation
(Hardy and Selkoe, 2002; Hardy, 2009).
The amyloid cascade model enjoys a dominant position in
studies of neurodegeneration. There is, however, some dissent.
This stems primarily from numerous conflicts between empirical
observations and the predictions of the model. Some of the most
prominent anomalies are as follows (see also Drachman, 2006;
Giannakopoulos et al., 2009; Pimpliker, 2009; Nelson et al., 2012):
(a) Neuritic plaques continuously occur in the brain of cogni-
tively unimpaired individuals.
(b) There is a weak correlation between the density of plaques
and the degree of dementia.
(c) Cognitively intact individuals have a significantly large inci-
dence of pre or post-mortem detected amyloid plaques.
These anomalies, and the consistent failure of clinical trials
designed to assess the efficacy of therapeutic strategies, have
stimulated various efforts to modify the premises of the model.
However, the amendments proposed (see Hardy, 2009) for an
evaluation, are all within the neuron-centric framework of amy-
loid production and clearance. Hence, they do not represent a
significant advance in our understanding of the molecular basis
of the sporadic forms of AD.
The amyloid hypothesis considers the sporadic forms of AD,
as a disease determined primarily by the instability of the nuclear
genome. The gene centered model essentially ignores the effect of
two factors, energy and age, which play critical roles in neurode-
generative diseases.
Energy is the primary determinant of neuronal viability.
Defects in energy metabolism may lead to a failure in the mainte-
nance and restoration of ion gradients associated with synaptic
transmission. In neurons, mitochondria are the main energy
producing organelles. The mitochondria generate energy by oxi-
dizing carbons derived from dietary carbohydrates and fat to
generate heat and ATP (Nicholls and Ferguson, 2002; Wallace
et al., 2010). The coherence of this process is determined by the
coupling efficiency of oxidative phosphorylation. Age is the crit-
ical determinant of the efficiency of energy production. Aging at
the molecular level is associated with the increase in molecular
disorder induced by random perturbations in the activity of large
biomolecules (see below for a description). These changes will
ultimately result in a decline in the coupling efficiency of oxidative
phosphorylation, and metabolic dysregulation (Hayflick, 2007a;
Demetrius, 2013).
Energy metabolism is altered by age. Cellular metabolism
invokes not only oxidative phosphorylation, an electrochemical
process, but also glycolysis, a chemical process. There is no sin-
gle gene for either of these processes, although genes do encode
the individual enzymes involved in both metabolic pathways.
Energy transduction by means of glycolysis is determined by a
sequence of chemical reactions which are localized in the cytosol.
In the case of oxidative phosphorylation, energy transduction is
contingent on two processes, the pumping of protons out of the
mitochondrial inner membrane by the electron transport chain,
and the conversion of proton flow into ATP (Lehninger, 1965).
The efficiency of these two processes is highly dependent on
the activity of the enzymes involved in the metabolic reactions.
Enzyme activity will decline with age in view of the intrinsic
thermodynamic instability of large biomolecules. This instability
will result in a loss of molecular fidelity and an impairment in
the capacity of the cells to appropriate energy from the external
environment and to convert this energy into biosynthetic work.
Consequently, the capacity of neurons to convert substrates such
as glucose and lactate into ATP and to use this energy to maintain
neuronal viability will also decline with age.
The model for the sporadic forms of AD proposed in
Demetrius and Simon (2012) as well as in Demetrius and Driver
(2013), implicates these two factors, energy and age, as the critical
elements in the origin of neurodegenerative diseases.
This neuroenergetic perspective posits that the primary cause
of sporadic forms of AD is an age-induced energy deficit in
the mitochondrial activity of neurons, and the up-regulation
of oxidative phosphorylation as a compensatory mechanism of
energy production to maintain the viability of the impaired cells.
The model contends that an age-induced mitochondrial dys-
function will initiate the following cascade of events which
ultimately results in neuronal loss and dementia:
(a) Metabolic alteration: A compensatory increase in oxidative
phosphorylation in order to maintain adequate energy pro-
duction, and thereby ensure neuronal viability.
(b) Natural selection:Competition for oxidative energy substrates
between healthy neurons, utilizing the standard modes of
energy production, and mildly impaired neurons, defined by
compensatory increases in OxPhos activity.
(c) Disease propagation: The spread of metabolic abnormali-
ties within the brain due to the selective advantage which
increased OxPhos activity confers to cells in the cerebral
microenvironment.
The model for the origin of cancer proposed by Warburg et al.
(1924) postulates that cancer is a metabolic disease initiated by
mitochondrial abnormalities, and subsequent metabolic alter-
ation to compensate for the diminished energy induced by
impaired mitochondria. The metabolic alteration proposed in
this model is the up-regulation of glycolytic activity. This mode
of metabolic reprogramming, now known as the Warburg effect,
is a well-established phenomenon in studies of the etiology and
proliferation of cancer. This is indicated by the widespread clini-
cal use of “18Fluorodeoxyglucose” position emission tomography
as a diagnostic marker for certain types of cancer.
Oxidative phosphorylation and glycolysis are complementary
mechanisms which cells utilize to meet their energy demands. We
have therefore called the up-regulation of OxPhos activity, which
we claim underlies the origin of sporadic forms of AD, the Inverse
Warburg effect.
The cornerstone of the neuroenergetic perspective is the com-
petition for oxidative energy substrates between healthy neurons,
that is neurons with normal OxPhos activity, and impaired
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neurons, cells with up-regulated OxPhos activity. The outcome
of this competition depends on the relative capacity of the two
types of neurons to appropriate energy substrates, and to convert
these substrates into ATP. This capacity is quantitatively described
by the statistical measure, evolutionary entropy, a measure of the
number of pathways of energy flow within a metabolic network
(Demetrius, 1997, 2013).
This paper will review the theoretical and empirical sup-
port for the Inverse Warburg hypothesis. We will re-evaluate
the amyloid hypothesis by contrasting its tenets with the
principles underlying the Inverse Warburg hypothesis. The
contrast between the two classes of models rests on the
following three criteria which characterize certain cellular,
demographic and epidemiological features of sporadic forms
of AD.
(i) Selective neuronal vulnerability—Neurons differ in terms of
their vulnerability to AD: The neurons providing the pro-
jection from entorhinal cortex to the dentate gyrus and the
pyramidal cells are themost vulnerable cell types. The differ-
ence in vulnerability reflects the usual course of the disease
in which episodic memory is the function affected in the
early stages of AD (Hof and Morrison, 2004).
(ii) Age as a risk factor—The Darwinian fitness of an organ-
ism, that is the capacity of the organism to contribute to
the ancestry of future generations is highly dependent on
age. Up to the age of reproductive maturity, there will be
intense selection to maintain the viability of the organism.
Such a maintenance increases the long term contribution
of the organism to the ancestry of successive generations.
After the age of reproductive maturity selection to main-
tain viability will be weak in view of its high metabolic
cost and the low contribution to Darwinian fitness which
such an investment inmaintenance confers (Hayflick, 2007a;
Demetrius, 2013). The age of reproductive maturity thus
represents a critical point in the vulnerability of an organ-
ism to age-related diseases. Up to this age, the random
age-related defects in the energy producing organelles will
be repaired and hence the incidence of metabolic diseases
will be rare. After the age of reproductive maturity, defects
will not be repaired. They will persist with highly cumu-
lative deleterious effects on the metabolic integrity of the
organism. Accordingly, the incidence of age-related dis-
eases, such as Alzheimer’s disease, will increase exponentially
with age.
(iii) Inverse cancer comorbidity—Biochemical and epidemiolog-
ical studies indicate that the sporadic forms of cancer and
age-related neurological disorders, such as Alzheimer’s dis-
ease (AD), Parkinson’s disease, (PD) and amyotrophic lat-
eral sclerosis (ALS) are inversely comorbid. This notion
refers to a lower than expected probability of disease
occurring in individuals diagnosed with other medical
disorders. The relation between cancer and AD is now
well documented. Cancer survivors have a lower risk of
AD than those with cancer. Prevalent AD is related to
a reduced risk for cancer, whereas a history of cancer
is associated with a reduced risk for AD (Roe et al.,
2010; Driver et al., 2012; Tabares-Seisdedos and Rubenstein,
2013).
We will show that these three criteria are inconsistent with the
amyloid hypothesis but concord with the predictions of the
Inverse Warburg model. This observation will be invoked as the
rationale for abandoning the amyloid hypothesis, and for advo-
cating the processes involving metabolic reprogramming and nat-
ural selection as the effective model for the origin and progression
of sporadic forms of AD.
The article is organized as follows: Section Bioenergetics out-
lines in quantitative terms the two principal modes of energy
production, oxidative phosphorylation and glycolysis, involved
in brain metabolism. Here we also describe how energetics in
the brain is based on the integration of these two modes of
energy production. Section The Origin and Progression of AD
describes the bioenergetic model of the origin of AD. We apply
the theory to distinguish between what we describe as normal
aging and pathological aging, and the transition from normal-
ity to pathogenesis. Within this conceptual framework, AD is a
derivative of pathological aging. Section Sporadic Forms of AD—
Genetic andMetabolic contrasts the Amyloid Cascademodel with
the Energetic selection model. Empirical support for the exis-
tence of the Inverse Warburg effect is summarized in Section
The Energetic Selection Model: Empirical Considerations. The
notion that the up-regulation of OxPhos activity in neurons
induces the sequence of events that could ultimately lead to
AD has important implications for diagnostic and therapeutic
strategies. These strategies are discussed in Section Therapeutic
Implications: Suppressing the Inverse Warburg Effect.
BIOENERGETICS
Our model for the origin of sporadic forms of AD postulates
that energy and age are the two critical elements which drive
the metabolic processes which culminate in neuronal loss, the
histopathological hallmark of AD. Oxidative phosphorylation
(OxPhos) and substrate phosphorylation are the principal mech-
anisms of energy production in cells. An understanding of the
activity of these two modes of energy production in ensuring that
the aging brain has sufficient energy is thus central in any study
of the origin of neurological diseases
OXIDATIVE PHOSPHORYLATION AND SUBSTRATE PHOSPHORYLATION
The main energy currency in living organisms is ATP which must
be continually available to maintain cell viability. The energy is
derived from two types of processes: OxPhos, which provides
about 88% of the total energy in most eukaryotic cells, includ-
ing neurons, and substrate phosphorylation (mainly glycolysis)
which contributes the remaining 12%. Oxidative phosphoryla-
tion occurs within the mitochondria. Electrons are transferred
to oxygen via a series of redox reactions to generate water. In
this process, protons are pumped from the matrix across the
mitochondrial inner membrane through a set of respiratory
complexes. When protons return to the mitochondrial matrix
down their electrochemical gradient, ATP is synthesized via the
enzyme ATP synthase. Energy production in this context is
electrochemical. The rate of energy production is determined
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by the conductance of the biomembrane and the electromotive
potential across the membrane (Nicholls and Ferguson, 2002).
Glycolysis occurs within the cytosol. The glycolytic enzymes
occur in relatively stable multienzyme complexes with metabo-
lites passed on from one active site to the next without exchanging
with the bulk cytoplasm. Energy production in this case is chem-
ical. The rate of energy production is now determined by the
activity of the glycolytic enzymes in the cytosol. In Figures 1, 2
are described the generation process of biological energy in the
case of oxidative phosphorylation and glycolysis, respectively.
Quantum metabolism (Demetrius et al., 2010), an analytic
theory of bioenergetics, provides a framework for deriving
FIGURE 1 | Oxidative phosphorylation. Coupled to the citric acid cycle,
oxidative phophorylation allows the oxidative degradation and energy
production from various energy substrates which include carbohydrates (in
particular glucose after its conversion into pyruvate via glycolysis), lactate,
ketone bodies or fatty acids. Both citric acid cycle and oxidative
phosphorylation take place within mitochondria and give rise to carbon
dioxide (CO2) and water (H2O) as waste products. ATP, Adenosine
triphosphate.
expressions for the metabolic rate of cells, and the dependence
of this rate on the mechanism of energy transduction, OxPhos, or
glycolysis. A cornerstone of the theory is the allometric relation
between metabolic rate, P, and cell size,W. This is given by:
P = αWd/d+ 1 (2.1)
FIGURE 2 | Glycolysis. Glycolysis is the non-oxidative part of the metabolic
pathway that allows the use of carbohydrates by eukaryotic cells. (1) The
Embden-Meyerhof pathway refers to the non-oxidative conversion of
glucose (a major carbohydrate) into pyruvate prior to its entry into the citric
acid cycle and its subsequent oxidation. Cytosolic NADH is reoxidized into
NAD+ through specific mitochondrial shuttles. (2) Anaerobic glycolysis
represents the conversion of glucose into lactate as an end product under
conditions of limited oxygen availability. Aerobic glycolysis describes the
same metabolic production of lactate as end product from glucose despite
adequate oxygen availability to normally carry on complete oxidation of
pyruvate. In these cases, cytosolic NADH is reoxidized within the cytosol by
the conversion of pyruvate into lactate via the enzyme lactate
dehydrogenase. ATP, Adenosine triphosphate; NADH, nicotinamide adenine
dinucleotide (reduced form).
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Here, the integer d in the scaling exponent satisfies the relation,
1 < d < ∞.
The proportionality constant α is contingent on the mecha-
nism of energy transduction, OxPhos or glycolysis. In the case
of OxPhos, the proportionality constant α is determined by the
proton gradient across the mitochondrial membrane. This quan-
tity is largely determined by the phospholipid composition of the
membrane. We have α= p, where:
p = ψ− cpH, (2.2)
Here ψ denotes the electrochemical gradient and pH, the pH
difference, and c a numerical constant. In the case of glycolysis,
α= k where:
k = c exp[−E/RT] (2.3)
Figure 3 shows the energy production associated with the con-
version of glucose to pyruvate and with the complete oxidation of
pyruvate to carbon dioxide and water as it occurs in aerobic cells
relying on glucose as their main energy substrate.
Glycolysis is a primitive way for anaerobic and facultative cells
to obtain energy. The primitive nature of the process is indi-
cated by the fact that the enzymes which catalyze the sequence
of reactions exist free in solution in the cytosol. Oxidative phos-
phorylation is an emergent property of energy production. The
enzymes which catalyze the reactions of the respiratory chain are
located in the inner membrane of the mitochondria, a complex
molecular fabric of lipid and protein molecules. In sharp contrast
to the enzymes involved in glycolysis, the enzymes of the electron
transport chain are located next to each other in the membrane
in the exact sequence in which they interact (Lehninger, 1965;
Harold, 2001).
The degree of organization of the enzymes in the cytosol
and the respiratory chain enzymes imposes constraints on the
metabolic rate generated by glycolysis and oxidative phosphory-
lation, respectively. In the case of glycolysis the metabolic rate will
be determined primarily by the kinetic activity of the enzymes,
as shown by Equation (2.2). However, the rate of energy pro-
duction, in the case of oxidative phosphorylation, will depend on
quantities such as the proton motive force, and the phospholipid
composition of the membrane, as indicated in Equation (2.1).
NEUROENERGETICS
The brain has important energy needs compared to other organs.
To satisfy them, it needs a constant supply of both oxygen and
nutrients. This is provided by an important and sustained cerebral
blood flow. Glucose represents by far the main energy substrate
for the adult brain. Most of the energy necessary to support brain
activity is generated by the metabolism and oxidation of glucose
via the tricarboxylic acid cycle coupled to oxidative phosphory-
lation in mitochondria (Magistretti, 2011). Changes in activity
within specific brain areas lead to localized enhancement in blood
flow as well as in glucose utilization. Failure to provide either oxy-
gen and/or glucose in adequate amounts even to a small brain area
can have rapid and dramatic consequences, e.g., ischemic neu-
ronal death, indicating the importance of energetics for proper
brain function.
FIGURE 3 | General model of energy transduction. In eukaryotic cells
that rely essentially on carbohydrates for their energy production, the
conjonction of glycolysis, the citric acid cycle and oxidative phosphorylation
is responsible for the production of energy as ATP. Upon complete oxidation
of energy substrates, both carbon dioxide (CO2) and water (H2O) are
produced. ATP, Adenosine triphosphate; NADH, nicotinamide adenine
dinucleotide (reduced form).
The contribution by the main cell types (neurons and glia)
constituting the brain to cerebral energy consumption has been
estimated (Attwell and Laughlin, 2001; Hyder et al., 2006). At rest,
the greatest portion of energy expenditure (∼87%) is attributed
to neurons while glial cells (with astrocytes being the domi-
nant type) account for only a small fraction (∼13%). Most of
the energy consumed by neurons is dedicated to re-establish the
ion gradients (via activity of the Na+, K+-ATPase) following
their depolarization, mostly by excitatory post-synaptic poten-
tials with a smaller contribution by action potentials (Alle et al.,
2009). Neurons are highly oxidative cells and contain numerous
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mitochondria. For a long time, it was considered that direct glu-
cose utilization and oxidation by mitochondria should be the
main source of ATP for neurons both at rest and during periods
of activity. Recent findings however questioned this view. It was
found that neurons exhibit a low level of expression of PFKFB3, a
critical enzyme for the regulation of glycolysis (Herrero-Mendez
et al., 2009). The consequence is that neurons have a lim-
ited capacity to upregulate glycolysis to face enhanced energy
demands. In contrast, astrocytes express high levels of PFKFB3
but also low levels of an important component of the malate-
aspartate shuttle, the aspartate-glutamate carrier aralar, which
is important for shuttling cytosolic NADH within mitochon-
dria and promoting glucose-derived pyruvate oxidation instead
of lactate formation (Ramos et al., 2003). Moreover, astrocytes
exhibit low levels of pyruvate dehydrogenase activity (Halim et al.,
2010). Modeling studies have shown that these characteristics
explain why neurons are essentially oxidative cells while astro-
cytes have such a high glycolytic capacity (Neves et al., 2012).
Furthermore, neurons have a low expression of the glyoxylases
1 and 2, two enzymes that are critical for metabolizing methyl-
glyoxal a toxic byproduct of glycolysis (Bélanger et al., 2011). In
contrast astrocytes can very effectively metabolize the glycolysis-
induced formation of methylglyoxal, and in fact protect neurons
against its toxicity (Bélanger et al., 2011). In parallel, it was shown
both ex vivo and in vivo that glucose utilization is lower than pre-
dicted by energy expenditures in neurons while it is the opposite
for astrocytes (Chuquet et al., 2010; Jakoby et al., 2014). These
observations have several important implications:
(1) To face higher energy demands, neurons cannot up-regulate
glycolysis and must rely entirely on an enhancement of
oxidative phosphorylation.
(2) To face higher energy demands, neurons cannot oxidize more
glucose-derived pyruvate (as their glycolytic capacity is lim-
ited) and must have access to another oxidative substrate
(most likely lactate).
(3) Astrocytes have constitutively high glycolytic rate giving rise
to elevated glucose consumption and lactate production as
opposed to neurons.
Astrocytes occupy a strategic position as they are often inter-
posed between blood vessels (the source of the main brain energy
substrate glucose) and neurons (Figure 4). Indeed, they possess
specific structures called end-feet that come in contact with cere-
bral blood vessels and cover almost entirely their surface. They
also have other processes that ensheath synapses, allowing them to
play important roles in relation with synaptic activity, e.g., recy-
cling the neurotransmitter glutamate. Several years ago, it was
proposed that lactate formed and released by astrocytes in an exci-
tatory activity-dependent manner could provide an additional
oxidative energy substrate for neurons (Pellerin and Magistretti,
1994). This model, known now as the Astrocyte-Neuron Lactate
Shuttle (ANLS; Pellerin and Magistretti, 2012), describes a cel-
lular and molecular mechanism (including lactate supply by
astrocytes to neurons) that provide an explanation for this partial
compartmentalization of glycolysis and oxidative phosphoryla-
tion in the central nervous system (Figure 5). It emphasizes also
FIGURE 4 | Cytoarchitectural relationships of astrocytes. Astrocytes (in
green) are in contact with cerebral blood vessels such as capillaries (in red)
through processes called endfeet. Moreover, astrocytes have other
processes in the vicinity of neurons (in blue) that also ensheath synapses.
the importance of a metabolic cooperation between neurons and
astrocytes to sustain neuronal activity.
Recent studies, reviewed in Zilberter et al. (2010), have indi-
cated the importance of lactate as a cerebral oxidative energy
substrate. The human brain can aerobically utilize lactate as an
energy substrate by the tricarboxylic acid cycle. A significant and
critical discovery is that the composition of the energy substrates
utilized by the brain is contingent on age, energy demands and
physiological conditions. During increased neuronal activity, sig-
nificant changes in the concentrations of the energy substrates
occur (Hu and Wilson, 1997; Pellerin et al., 2007). Glucose
concentration is lowered and lactate concentration is increased,
indicative of an enhanced activity of the astrocytes.
The Inverse Warburg hypothesis as it will be developed in
the following sections requires only that the lactate produced
by astrocytes is a source of energy for neurons. Although the
biochemical details of how it is produced and transferred to neu-
rons are not relevant to the Inverse Warburg hypothesis, the
ANLS model provides an interesting conceptual framework to
further explore the implications of an energetic dysfunction in
Alzheimer’s disease. For this reason, it has been integrated in the
description of the processes encompassed by the Inverse Warburg
hypothesis. However, it is important to make it clear that the
InverseWarburg hypothesis described herein does not rely on this
model for its own validity, although it certainly raises its appeal.
THE ORIGIN AND PROGRESSION OF AD
Epidemiological data distinguish between early onset and late
onset AD. A small minority of individuals are afflicted with the
early onset form of the disorder. This is an autosomal dominant
form attributable to mutations in three genes, APP, presenilin 1
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FIGURE 5 | The Astrocyte-Neuron Lactate Shuttle Hypothesis of
activity-dependent regulation of neuronal energy substrate supply by
astrocytes. At excitatory synapses, glutamate is released in the synaptic
cleft upon activation. Its action on post-synaptic receptors is terminated
by its reuptake in astrocytes through high affinity, glial-specific glutamate
transporters (EAATs). Glutamate is converted into glutamine and released
by astrocytes via a specific glial glutamine transporter. Glutamine will be
taken up by neurons from the extracellular space via a neuron-specific
glutamine transporter and glutamine will be converted to glutamate before
being accumulated in synaptic vesicles. In parallel, glutamate uptake into
astrocytes will trigger an increase in glycolysis, with an enhancement of
glucose uptake from the blood circulation into astrocytes via specific
glucose transporters (GLUTs) on both endothelial cells and astrocytes.
Lactate produced by astrocytes will be released in the extracellular space.
To face their increased energy demands following synaptic activation,
neurons will take up more lactate and oxidize it to produce more ATP.
Neurons also take up glucose from the circulation via a specific glucose
transporter. Part of the glucose can be metabolized through glycolysis
and then oxidized in mitochondria to provide ATP. However, a significant
amount of glucose is metabolized in neurons through the Pentose
Phosphate Pathway (PPP) in order to regenerate NADPH necessary as
cofactor for enzymes involved in antioxidant defenses.
and presenilin 2. The expression of the disease follows a pattern
of Mendelian inheritance. Hallmarks of the disease are the forma-
tion of neurofibrillary tangles (Tau aggregates and the deposition
of amyloid plaques; see Figure 6).
The age of incidence is a random variable whose distribution
has the form of a bell-shaped curve described by a minimum and
maximum age of onset of 35 and 65 years, respectively, and a
mean age of 50 years (Hendrie, 1998; Swerdlow, 2007).
The late onset form of the disease does not follow Mendelian
inheritance, although it shows some degree of heritability. There
exist a number of genetic risk factors for AD. However the major
risk factor is age. The age of onset is about 70 years, and disease
prevalence increases exponentially with age.
The symptoms of AD are initially very mild. They then slowly
progress. The neuronal cell types show selective vulnerability.
Neurodegeneration typically begins in the entorhinal cortex, and
then spreads to the hippocampus and parietal regions of the neo-
cortex, Hof and Morrison (2004). Both the early and late onset
forms of the disease show similar histopathological changes.
The amyloid cascade hypothesis and the energetic selection
model are two conceptual frameworks that have been invoked to
explain the origin of sporadic forms of AD (Hardy and Selkoe,
2002; Hardy, 2009; Demetrius and Simon, 2012; Demetrius and
Driver, 2013). Both models acknowledge the epidemiological fact
that age is a primary risk factor for the disease. However, the effect
of age on the dynamics of neurodegeneration is analyzed in quite
distinct ways.
THE AMYLOID CASCADE MODEL
The amyloid cascade hypothesis is based on a neuron-centric
characterization of the origin and development of the disease.
The model essentially does not take into account the interac-
tion between neurons and astrocytes in disease progression. The
beta amyloid moieties, the presumed biochemical hallmarks of
neurodegeneration, are assumed to be generated by abnormal
processing of APP. Age in the context of this model is considered
uniquely in terms of its influence on the toxicity of the peptide
beta amyloid. In this model, age reflects the time it takes beta
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amyloid to attain concentrations which are sufficient to impair
neuronal function. Accordingly, the sporadic form of the disease
can be considered to be determined primarily by the net produc-
tion rate of beta amyloid. Since this biochemical abnormality is
FIGURE 6 | Molecular mechanism involved in the β-amyloid cascade
hypothesis of Alzheimer’s disease. Mutations in the Amyloid Precursor
Protein (APP) gene will induce a cascade of events leading to neuronal cell
death. Hyperphosphorylation of the Tau protein is one manifestation of the
β-amyloid cascade which has for consequence the formation of
NeuroFibrillary Tangles (NFTs, in purple). In parallel, APP mutations cause
erroneous β-amyloid protein processing and β-amyloid deposition in senile
plaques.
assumed to be determined by aberrant processing of APP, the
early onset and sporadic forms of the disease can be ascribed
the same etiology. The sporadic form of AD is thus a conse-
quence of genomic instability, primarily the result of mutations
in the nuclear genome, and hence can be considered to be a
genetic disease. The sequence of pathogenic events leading to AD,
in accordance with the amyloid cascade hypothesis is shown in
Figure 7.
THE INVERSE WARBURG HYPOTHESIS
The neuroenergetic model is based on a neuron-astrocytic char-
acterization of energy supply and demand in neuronal and
glial cells. This model recognizes that brain energy metabolism
involves both neurons and astrocytes (Pellerin and Magistretti,
1994, 2012). Both cell types utilize glucose as an energy source.
In astrocytes, a significant proportion of glucose is metabo-
lized aerobically to lactate which is released into the extracellular
milieu. In neurons, glucose-derived and lactate-derived pyruvate
is metabolized aerobically, oxidative phosphorylation being the
predominant mode of energy production. Neurons are unable
to increase energy production through glycolysis owing to the
lack of activity of some glycolysis promoting enzymes (Bolanos
et al., 2010). Hence when some of the mitochondria in neurons
become impaired, the associated increased demand for energy is
achieved by the action of two events. The first is the up-regulation
of glycolysis in astrocytes, a metabolic reprogramming which
results in increased production of lactate. The second is the up-
regulation of OxPhos activity in neurons, which will use more
FIGURE 7 | Amyloid cascade hypothesis: a gene-centric model. A
mutation in the amyloid gene or one of the genes involved in amyloid
processing (e.g., presenilin) will provoke an imbalance between amyloid
production and clearance. As a consequence, amyloid deposition will take
place, forming amyloid plaques, and neurofibrillary tangles will also appear.
Neuronal death will ensue, leading progressively to dementia.
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FIGURE 8 | Warburg effect. Under certain conditions (e.g., tumorigenicity,
proliferation), aerobic glycolysis becomes the predominant form of
carbohydrate metabolism and energy production, at the expense of citric
acid cycle and oxidative phosphorylation. One characteristic of this
metabolic imbalance is the upregulation of several proteins and enzymes
involved in glycolysis and/or in its regulation. Among others, they include
the transcription factor HIF-1α, or the enzyme isoforms PKM2, PDK1, and
LDHA. ATP, Adenosine triphosphate; HIF-1α, Hypoxia Inducible Factor-1α;
LDHA, Lactate dehydrogenase A; NADH, nicotinamide adenine
dinucleotide (reduced form); PDK1, Pyruvate dehydrogenase kinase 1;
PKM2, Pyruvate kinase M2.
lactate produced by astrocytes as an additional source of energy.
The up-regulation of glycolysis and the up-regulation of OxPhos
activity are two complementary modes of metabolic reprogram-
ming. The first is called theWarburg effect (Figure 8), the second,
the Inverse Warburg effect (Figure 9).
Age, in the context of this neuroenergetic model, is defined
in terms of its effect on the aggregation dynamics of the cel-
lular proteins, and the metabolic capacity of aged neurons. At
the molecular level, the aging process is driven by an increase in
molecular disorder and a concomitant decrease in the activity of
the enzymatic processes (Hayflick, 2007a). Aging can result in the
decline of chaperone and proteasome responses to protein aggre-
gation and hence to amyloid formation. At themetabolic level, the
aging process will induce a decrease in the efficiency with which
neurons appropriate caloric energy and transform this energy
FIGURE 9 | Inverse Warburg effect. In some instances (e.g., during aging),
mitochondrial dysregulation leads to a dysproportionate upregulation of
oxidative phosphorylation. In such case, an enhancement in the expression
of all complexes (I–V) composing the respiratory chain has been
documented. In addition to carbohydrate-derived pyruvate, cells become
critically dependent on other oxidative substrate sources such as
lactate-derived pyruvate. ATP, Adenosine triphosphate.
into ATP. The neuroenergetic model posits that this reduced effi-
ciency will trigger a cascade that involves the up-regulation of
oxidative phosphorylation in neurons, oxidative stress and fur-
ther damage to mitochondria, fuel shortage, neuronal loss and
dementia (Figure 10).
The mitochondria in neurons are the energy producing
organelles. This energy depends on the proper functioning of the
metabolic network whose efficiency is contingent on the mainte-
nance of the precise three dimensional structures of the biological
molecules. The increase in molecular disorder which the aging
process induces is a consequence of the intrinsic thermodynamic
instability of these complex biomolecules (Hayflick, 2007b).
Molecular disorder can be analytically described in terms of
the concept thermodynamic entropy, denoted S. Thermodynamic
entropy has both a statistical and a macroscopic representation.
The statistical representation is due to Boltzmann and is given by:
S = k logW
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FIGURE 10 | The transition to AD: a neuroenergetic model. As a
consequence of aging, mitochondrial dysregulation occurs which will
lead to an upregulation of oxidative phosphorylation as well as
oxidative stress. Since upregulated mitochondrial oxidative activity
will require more energy substrates to produce the same amount
of energy, it will eventually lead to an energy shortage, especially
for the other cells that have not undergone upregulated oxidative
phosphorylation. Neurons that cannot compete for energy
substrates and produce sufficient amount of energy will eventually
die, leading progressively to dementia.
The constant k is Boltzmann’s constant. The quantityW is a mea-
sure of the number of ways that the molecules of a system can
be arranged to realize the same total energy. In qualitative terms,
S describes the extent to which the energy in the system is spread
out over the variousmicroscopic storagemodes. Themacroscopic
representation, which is due to Clausius is given by:
dS = dQ
T
(3.1)
Here dS denotes the change in entropy which occurs when an
energy dQ is transferred as heat to the system. The quantity T
denotes the temperature at which the transfer took place.
The Second Law of thermodynamics asserts that in isolated
systems, the thermodynamic entropy will increase. We can exploit
this principle to explain the inevitable decrease in the ability of
complex biomolecules to maintain their three dimensional folded
state, and hence their function and catalytic activity. The inher-
ent, thermodynamic instability of protein molecules entail that
conformational alterations and aggregation will occur, leading to
misfolded structures (Chiti and Dobson, 2009).
The increase in thermodynamic entropy will also have an effect
on molecular fidelity and hence an increase in the mutation
rate of mitochondrial DNA (Hayflick, 2007a). These age-specific
changes will also affect the kinetic activity of the various enzymes
involved in reactions which transform the energy contained in
substrates, like glucose and lactate, into energy which can be
used to maintain the integrity of synaptic connections. The
effect of these alterations in kinetic activity will be a decrease
in the efficiency of the metabolic process—a condition which
can be described in terms of a decrease in evolutionary entropy
(Demetrius, 2013). Evolutionary entropy is a measure of dynam-
ical organization of biological networks, that is systems which
appropriate resources from the external environment and con-
vert these resources into chemical energy. These networks include
energy producing systems such as the glycolytic and oxidative
phosphorylation systems in cells, demographic systems in which
the individual elements are different stages in the individual life
cycle. Evolutionary entropy describes the number of pathways of
energy flow within a biological network. As is the case with ther-
modynamic entropy. Evolutionary entropy admits both statistical
and macroscopic representations (Demetrius, 2013).
The statistical representation, an analog of the Boltzmann
entropy, is given by:
S˜ = k˜ log W˜
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Here k˜ is a numerical constant. The quantity W˜ denotes the
number of pathways of energy flow within the network.
Glycolytic and oxidative phosphorylation networks are
described in terms of a small and a comparatively large number of
pathways of energy flow, respectively. This entropy measure also
describes the rate at which the system appropriates energy from
the external environment, and converts this energy into cellular
work.
The macroscopic representation of evolutionary entropy is:
dS˜ = −T˜dP˜ (3.2)
The relation given by Equation (3.2) describes the change in
entropy dS˜ which occurs when a quantity of energy, as measured
by the change in metabolic rate dP˜ is introduced to the system,
which is processing energy with a cycle time or turnover time T˜.
Our model posits that the aging process will induce pertur-
bations at both molecular and cellular levels. The changes at the
molecular level are the result of an increase in thermodynamic
entropy. These entropic changes are associated with an increase in
molecular disorder, and will induce mutations in mitochondrial
DNA andmisfolding of various proteins. Amyloidosis, in the con-
text of this model, is primarily a consequence of aging, and its
bioenergetic signature, thermodynamic instability.
The changes at the cellular level are the result of a decrease
in evolutionary entropy. These entropic changes will result in
metabolic dysregulation, and a decrease in the energy production
of neuronal cells.
The mitochondrial dysregulation which the aging process
induces will have critical effects on the capacity of impaired
neurons to maintain ATP levels which are necessary to ensure
metabolic homeostasis. The Inverse Warburg hypothesis postu-
lates the following cascade of events as the adaptive response to
the bioenergetic stress caused by mitochondrial deficits.
(a) Metabolic alteration. This pertains to the Inverse Warburg
effect, the up-regulation of OxPhos activity in the impaired
neurons to compensate for the diminished efficiency of
energy production.
This mode of metabolic reprogramming recognizes the
inherent complexity of mitochondrial dynamics. The large
requirements of neuronal energy is achieved by the fission
and fusion of mitochondria to generate smaller or elon-
gated organelles (Van Laar and Berman, 2013). In impaired
neurons, a small subset of mitochondria may become defec-
tive with age, while the other organelles remain intact. The
metabolic alteration we postulate involves an increase in
OxPhos activity in the intact mitochondria, and a redistribu-
tion of these mitochondria to sites which require high energy
production. Such movement of mitochondria in neurons has
already been documented (Chang and Reynolds, 2006).
(b) Natural selection. This process describes competition for lac-
tate (generated by astrocytes) as the preferred oxidative sub-
strate between intact neurons (Type I), with normal OxPhos
activity, and impaired neurons (Type II), with up-regulated
OxPhos activity (Figure 11). The outcome of competition
FIGURE 11 | Changes in neuronal energetic efficiency during normal
aging. Neurons rely heavily on oxidative metabolism for obtaining their
energy from nutrients. This process takes place in mitochondria. Healthy
neurons with maximal energetic efficiency are designated type I neurons.
During normal aging, mitochondrial instability and dysfunction appears,
notably caused by the reduction of antioxidant defenses and the formation
of oxygen free radicals. As a consequence, certains neurons will undergo a
reduction in energetic efficiency and higher metabolic rate, requiring more
nutrients to sustain their energy needs. These neurons are called type II
neurons.
between the two classes of neurons is described by the
entropic selection principle.
According to the entropic selection principle the outcome of com-
petition between an incumbent population of cells and a variant
population is predicted by evolutionary entropy, and is contin-
gent primarily on resource abundance and resource composition.
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The evolutionary entropy of the neuron is defined in terms of the
number of pathways of energy flow in the oxidative phosphory-
lation network. Neurons with up-regulated OxPhos activity have
a high evolutionary entropy, when compared with neurons with
normal OxPhos activity (Demetrius and Simon, 2012, 2013).
The microenvironment generated by the metabolic activity of
astrocytes will be characterized by lactate, Astrocytes, like neu-
rons, also age. Accordingly, lactate production in older individuals
will be limited. This limited resource constraint, according to
the selection principle, entails that neurons with up-regulated
OxPhos activity (the impaired neurons), will outcompete neu-
rons with normal OxPhos activity (the intact neurons). This
means that the impaired neurons will have a selective advantage
and increase in frequency.
The integrative action of metabolic reprogramming and natu-
ral selection on the neuronal population will be a gradual change
in the distribution of intact and impaired neurons, resulting in
a decrease in frequency of the normal cells, and an increase in
frequency of the dysfunctional cells.
NORMAL AGING AND PATHOLOGICAL AGING
The cascade of events generated by the three processes, mitochon-
drial dysfunction, metabolic alteration, and natural selection, can
be more clearly delineated by appealing to concepts drawn from
dynamical systems theory to distinguish between two gerontolog-
ical stages, normal and pathological aging (Demetrius and Simon,
2013).
Normal aging is characterized by the incidence of intact
and dysfunctional neurons in a quasi-stable equilibrium state.
Impaired or dysfunctional neurons are defined by changes at the
molecular and cellular levels. The changes at the molecular level
involve an accumulation of amyloid plaques—a result of mis-
folded proteins. The alteration at the cellular level will reflect the
effects of diminished energy production.
The quasi-stable state which defines the distribution of rela-
tively intact neurons and impaired neurons will be maintained
by various response mechanisms which have evolved to preserve
cognitive function across an entire life span. These mechanisms
include:
(i) The action of anti-oxidant enzymes.
These enzymes mitigate the deleterious effects caused by the
excessive production of reactive oxygen species (ROS) generated
by neurons with up-regulated OxPhos activity.
(ii) The action of signal transduction enzymes.
These enzymes repair defects in cell-cell signaling in neurons—an
impairment which will occur when there is a significant decline in
energy production due to impaired efficiency in enzymes in the
electron transport chain.
(iii) The activation of neuroprotective genes.
The repressor element 1-silencing transcription factor (REST)
is a universal property of normal aging in human cortical and
hippocampal neurons (Lu et al., 2014). REST represses genes
that promote neuronal loss and induces the expression of stress
response genes.
Pathological aging is induced by a disruption of the quasi-
stable state involving intact and impaired neurons. This dysreg-
ulation of the equilibrium condition will be generated by various
insults which will impair the activity of the mechanisms which
have evolved to preserve cognitive function and protect against
neuronal loss in the aging brain. The morphological signature
of pathological aging is a decreased synaptic density and loss of
synaptic function. The cellular hallmarks are neuronal loss and
loss of dendritic branching. A comparison between the features
of normal and pathological aging is described in Table 1.
According to the energetic selection model for AD, neuronal
loss is the histopathological signature of the disease following the
collapse in the action of the various neuroprotective mechanisms
that enhance neuronal viability. A factor which plays a central
role in the transition toward pathological aging is oxidative stress.
Under normal conditions, neurons never enter the cell cycle and
once mature, they no longer have the capacity to complete mito-
sis. Oxidative stress is one of the factors which leads to abnormal
cell cycle entry and ultimately neuronal loss.
SPORADIC FORMS OF AD—GENETIC AND METABOLIC
The peptide beta amyloid is constantly produced in the brain of
young and old people. Extracellular beta amyloid levels rise dur-
ing the day and fall at night (Huang et al., 2012). In the healthy
brain, beta amyloid production and clearance is tightly regulated.
In the unhealthy brain, the production and clearance is dysregu-
lated. These considerations are of critical importance in both the
amyloid hypothesis and the neuroenergetic model. However, the
role which beta amyloid plays in the depictions of sporadic forms
of AD are quite distinct and derive from different assumptions
regarding the origin and the progression of the disease.
The amyloid cascade model is a neuron-centric analysis of
disease origin and progression. The argument considers the pro-
gression of the disease in an energetically closed system which
ignores the interaction of neurons with astrocytes. According to
this model, neuronal loss is due to the formation of senile plaques
generated by the loss of homeostatic regulation of beta amyloid.
The Inverse Warburg hypothesis is a neuron-astrocytic depic-
tion of the transition to AD in which the mitochondria occupies
the central and fundamental role. The model recognizes that
brain energy metabolism involves both neurons and astrocytes
and their interaction. The sporadic forms of AD, according to
this model are driven by the aging process which acts on the
Table 1 | Comparison: normal and pathological aging.
Comparison Normal aging Pathological aging
Clinical Mild defects in short
term memory
Severe defects in short term and
long term memory
Molecular Mild accumulation of
amyloid plaques
Severe and diffuse accumulation
of amyloid plaques
Cellular Impaired synaptic
function
Neuronal loss and synaptic loss,
loss of dendritic branches
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mitochondria, which are vulnerable organelles because of their
high mutation rates.
The notion that mitochondrial dysfunction is a key factor in
age-associated neurodegenerative diseases has been articulated
in several publications (Blass, 2000; Beal, 2005; Wallace, 2005;
Swerdlow, 2007; Reddy, 2008; Yao and Brinton, 2011). These vari-
ous studies have emphasized the role of age and energy in a variety
of neurodegenerative diseases.
The Inverse Warburg hypothesis we have described builds
on these empirical observations. The novelty of the energetic
selectionmodel as it pertains to the origin of age-related neurode-
generative diseases, rests on three critical factors, namely:
(a) The analytic integration of mitochondrial energetics in neu-
rons with the cytosolic energetics in astrocytes—the ANLS
shuttle hypothesis (Pellerin and Magistretti, 1994). It is note-
worthy that the ANLS concept has been related to a similar
phenomenon observed in the cancer field (known as the
Reverse Warburg effect) whereby a support cell exhibits a high
glycolytic activity in order to fuel a more oxidative neighbor
cell (Pavlides et al., 2010).
(b) The promulgation of the concept of metabolic repro-
gramming (i.e., increased oxidative phosphorylation) as a
compensatory mechanism to meet the energetic demands
induced by mitochondrial dysfunction in neurons—the
Inverse Warburg effect (Demetrius and Simon, 2012).
(c) The phenomenon of natural selection—competition between
intact and impaired neurons for alternative fuel sources—
the entropic selection principle (Demetrius, 1997; Demetrius
and Driver, 2013).
It is of some interest to note that the astrocyte-neuron lactate
shuttle (Pellerin and Magistretti, 1994) which is postulated here
to regulate energy transduction in Alzheimer’s disease is anal-
ogous to what we will describe as the stromal-epithelial lactate
shuttle in oncology (see Pavlides et al., 2010). Both bioenergetic
processes involve a system whereby support cells exhibit high
glycolytic activity in order to fuel oxidative neighbor cells. In
brain, the support cells are the astrocytes; in tumors, the sup-
port cells are stromal fibroblasts. The phenomenon of metabolic
alteration as an adaptive strategy is observed in both neu-
rodegeneration and tumorigenesis. Mitotic cells such as tumors
can utilize both glycolysis and oxidative phosphorylation as
means of energy production. Hence metabolic shifts to gly-
colysis or OxPhos activity are both viable adaptive options.
The up-regulation of glycolysis in cancer cells is called the
Warburg effect. The up-regulation of OxPhos activity, the reverse
Warburg effect.
Post-mitotic cells such as neurons lack the capacity to make
a compensatory metabolic shift to glycolysis due to the weak
activity of the key glycolytic enzymes. Accordingly, a metabolic
shift to up-regulate oxidative phosphorylation is the only viable
adaptive strategy. We have called this metabolic alteration, the
Inverse Warburg effect. The reverse and inverse Warburg effects
are distinct phenomena, the first referring to mitotic cells, such as
cancer; the second to post-mitotic cells such as neurons.
AMYLOID CASCADE HYPOTHESIS AND THE INVERSE WARBURG
HYPOTHESIS: A CONTRAST
The amyloid hypothesis is a neuron-centric argument. This
model does not explicitly consider the interaction between neu-
rons and the neuronal microenvironment. The Inverse Warburg
hypothesis is a neuron-astrocytic model which takes into account
the fact that astrocytes provide the energy source tomaintain neu-
ronal viability. We will contrast these two competing hypotheses
by assessing their capacity to accomodate and explain three dis-
tinct hallmarks of AD. These disease hallmarks can be described
as follows:
(1) Selective vulnerability: Neuronal populations are character-
ized by differential sensitivity to stress that cause cell injury
and death. Hippocampal and frontal lobe pyramidal neurons
are highly vulnerable cell types, whereas dentate gyrus gran-
ule neurons and cortical interneurons are resistant to injury
(Hof and Morrison, 2004; Mattson and Magnus, 2006).
(2) Age-dependence: The disease has an age of onset of about
70 and the age-specific incidence rate increases exponentially
with age (Hendrie, 1998; Swerdlow, 2007).
(3) Comorbidity: There exists an inverse comorbidity between
cancer and Alzheimer’s disease. People with certain sporadic
forms of cancer are protected against AD, whereas people
without a history of cancer have a high risk of AD (Driver
et al., 2012).
These three conditions represent critical biochemical and epi-
demiological aspects of sporadic forms of AD. Consequently,
any model that purports to provide a mechanism for the origin
and progression of the disease should be consistent with these
biochemical and epidemiological hallmarks.
We will now contrast the explanatory power of the amyloid
cascade hypothesis and the Inverse Warburg hypothesis by assess-
ing the extent to which each model is consistent with the three
properties: selective neuronal vulnerability, age-specific incidence
rate and inverse cancer comorbidity.
(i) Selective neuronal vulnerability
The differences in the vulnerability of neurons to AD derive essen-
tially from differences in the demand for energy to maintain their
viability and to perform their function.
According to the Amyloid cascade hypothesis, neuronal loss is
due to the toxicity of beta amyloid. However, since beta-amyloid
derives from processing of the APP gene, which will be the same in
each cell type under the amyloid cascade model, the vulnerability
of each neuronal type should be essentially random and non-
selective. This prediction of the amyloid hypothesis, however, is
inconsistent with the selective neuronal vulnerability.
Selective vulnerability, however, is consistent with the ener-
getic selection model. The main tenet of this model, the up-
regulation of OxPhos activity as a compensatory response to
impaired energy production, underscores its bioenergetic basis.
The vulnerability of neurons depends on their energy demands in
times of stress. Neurons providing the projection from entorhinal
cortex to dentate gyrus and pyramidal cells have stronger energy
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demands, and are therefore most vulnerable (Hof and Morrison,
2004). Selective differences in neuronal vulnerability are thus an
immediate derivative of the energetic selection model.
(ii) Age-specific incidence rates
The amyloid hypothesis assumes that the sporadic form of AD is
primarily a genetic disease initiated by mutations in the nuclear
genome. Age in this model is considered a measure of the time
required for biochemical abnormalities to attain certain toxic
concentrations (Figure 12). The age-incidence rate of the disease
will therefore be determined by the genetic constitution of the
population and the environmental factors. The effects of these
processes on disease expression can be considered independent
and additive. Consequently, the age-specific incidence rate of
diseases subject to these constraints will be bell-shaped.
The Inverse Warburg hypothesis assumes that the sporadic
form of AD is primarily a metabolic disease initiated by mito-
chondrial dysfunction. Age, in the framework of this model,
determines pathogenesis by means of an increase in molecular
disorder, a loss of molecular fidelity, and a decrease in efficiency
of the metabolic processes. These effects are interdependent, and
the intensity of their action on neuronal dynamics will be cumu-
lative. Accordingly, the age-specific incidence rate of the disease
will increase exponentially with age.
The epidemiological studies of the age-incidence rate of AD
indicate an exponential increase (Hendrie, 1998). This fact does
not support the neuron-centric model of AD. However, the
empirical observations are consistent with the energetic selec-
tion model which considers AD as a metabolic disease. In the
case of normal aging, despite the appearance of neurons with
dysfunctional mitochondria, the system remains in an equilib-
rium state (Figure 13). This is due to the neuroprotective mech-
anisms activated to preserve homeostasis (Described in section
The Origin and Progression of AD). In contrast, pathological
aging results from an imbalance in these processes, accelerating
the appearance of mitochondrial dysfunction. When this occurs
in the context of natural selection imposed by the neuronal
microenvironment, the imbalance will become amplified, leading
to loss of both Type I neurons, due to their selective advantage,
and Type II neurons, due to increased oxidative stress (Figure 14).
(iii) Inverse Comorbidity
Conditions for the inverse comorbidity of cancer and AD can be
described in terms of the following properties:
(a) Epidemiological: The age incidence rate of the two diseases
have similar statistical distributions
(b) Biochemical: If the enzymes in themetabolic pathways in two
populations of individuals of the same age are subject to reg-
ulatory changes in the same direction, and generate negative
correlated metabolic effects, then the probability of indi-
viduals being diagnosed with the diseases will be inversely
related.
Although the amyloid cascade model may be consistent with the
biochemical criterion, it is evidently inconsistent with the epi-
demiological condition. It is an established fact that the sporadic
forms of most cancers are described by an age-incidence rate
which increases exponentially with age. However, according to
the amyloid cascade model, the age-incidence of AD will be a
FIGURE 12 | Brain pathological evolution to Alzheimer’s disease with
age according to the β-amyloid cascade hypothesis. Amyloid Precursor
Protein (APP) gene mutations present in all neurons will cause the
appearance in the most vulnerable neurons of NeuroFibrillary Tangles (NFT) in
asymptomatic patients (YOUNG). With time, β-amyloid plaques will form and
some neurons will eventually die (OLD). Progressively, more and more
neurons will enter this process leading to the signs of cognitive decline
characteristic of Alzheimer’s disease.
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FIGURE 13 | Brain metabolic changes during normal aging. Brain of
young individuals is composed of normal type I neurons which are
fed with lactate produced by astrocytes from glucose provided by the
circulation (YOUNG). In normal aging, a few abnormal type II neurons
with mitochondrial instability and dysfunction will appear but the
increase in energy demands caused by these neurons can be met by
the lactate production of astrocytes (HEALTHY OLD). Glu, Glucose;
Lac, Lactate.
bell-shaped distribution. This implication is inconsistent with the
epidemiological fact that cancer and AD are inversely comorbid.
The Inverse Warburg hypothesis, however, is consistent with
both biochemical and epidemiological criteria. The consistency
with biochemical conditions derives from the metabolic charac-
terization of the Warburg and the Inverse Warburg effects. The
Warburg effect can be considered an oncologic phenomenon. It
pertains to the up-regulation of glycolysis to compensate for the
impairment in energy production due to mitochondrial dysfunc-
tion in differentiated cells.
The InverseWarburg effect can be considered a neuroenergetic
phenomenon. It refers to the up-regulation of oxidative phospho-
rylation to compensate for the impairment in energy production
due tomitochondrial dysfunction in neuronal cells. The glycolytic
enzyme PFKFB3 is a critical directive in both modes of metabolic
reprogramming. In cancer cells, the metabolic reprogramming
involves an up-regulation of the enzyme PFKFB3 (Yalcin et al.,
2009). In neurons, as the activity of the glycolysis-promoting
enzyme PFKFB3 is maintained low by its constant proteasomal
degradation, activation of glycolysis is prevented, thus favoring an
enhancement of oxidative phosphorytion to face increased energy
needs (Bolanos et al., 2010).
An increased glycolysis will involve an up-regulation of this
key glycolytic enzyme and results in a high risk for the unlim-
ited proliferation that defines the cancer phenotype. An increased
OxPhos activity in the context of a lack of activity of the same key
glycolytic enzyme would result in a high risk for the neuronal loss
which characterizes the Alzheimer phenotype.
A strong activity of such a key enzyme will increase the risk
of cancer but decrease the risk of AD. We can infer from these
observations that cancer and AD will be inversely comorbid. This
prediction is consistent with the epidemiological studies con-
trasting the incidence of both diseases. The consistency of the
Inverse Warburg hypothesis with the epidemiological criteria is
a result of the fact that age generates pathogenesis as a result of
the cumulative increase in molecular disorder and metabolic dys-
regulation. Table 2 describes and contrasts the two mechanisms
for AD, the amyloid hypothesis and the Inverse Warburg model,
in the light of the demographic and epidemiological properties
we have delineated.
THE ENERGETIC SELECTION MODEL: EMPIRICAL
CONSIDERATIONS
There exists a body of empirical studies which investigate the
incidence of the up-regulation of OxPhos activity as a compen-
satory response to impairment in energy metabolism as a result
of genomic or metabolic factors. These investigations have been
carried out in both cell culture contexts and in transgenic mouse
models. We will appeal to these studies in furnishing empirical
support for the Inverse Warburg effect.
THE UP-REGULATION OF OxPhos ACTIVITY: CELL CULTURE STUDIES
Empirical support for this mode of metabolic reprogramming is
based largely on studies of hippocampal neurons—the cell type
which is most vulnerable to mtDNA damage and impairment in
metabolic dysregulation (Nagy et al., 1999; Zhu et al., 2006).
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FIGURE 14 | Brain metabolic changes during pathological aging
leading to Alzheimer’s disease according to the Inverse Warburg
hypothesis. In pathological aging, the number of type II neurons with
mitochondrial instability and dysfunction increases importantly, requiring a
more important share of the lactate produced by astrocytes to sustain
their energy needs (PATHOLOGICAL OLD). With time, as the number of
type II neurons continue to rise, normal type I neurons do not receive
enough lactate to support them, leading to damage and conversion as
type II neuron and/or cell death (SPORADIC ALZHEIMER). Glu, Glucose;
Lac, Lactate.
Table 2 | Amyloid cascade hypothesis and Inverse Warburg
hypothesis.
Properties Amyloid cascade
hypothesis
Inverse Warburg
hypothesis
Neuronal
vulnerability
Random and
non-selective
Selective
Age-specific disease
incidence rate
Bell-shaped Exponential increase
with age
Comorbidity Absence of comorbidity Inverse comorbidity
Zhu et al. (2006) have observed that levels of mtDNA and
cytochrome oxidase (COX1) are markedly increased in hip-
pocampal neurons of Alzheimer’s patients even though the num-
ber of mitochondria per neuron is decreased. The increase in
COX activity can be interpreted as the up-regulation of OxPhos
activity—a compensatory action to mitigate the effect of dimin-
ished energy production in the highly damaged mitochondria.
Nagy et al. (1999) have also observed an increase in COX1 activity
in the mitochondria of neurons which have a diminished energy
production. In these studies, neuronal COX activity increases
with increasing age and shows a decline only with very old age.
The increase in COX activity is consistent with the up-regulation
of OxPhos as a compensatory mechanism. The decrease at very
old ages reflects the loss of neuronal connections at advanced
stages of the disease, that is, with the accumulation of AD-related
pathology. Comparable decreases at very old age has also been
documented by Chandrasekeran et al. (1998).
These experimental observations indicate that the up-
regulation of OxPhos activity in neurons is a common mecha-
nism to compensate for diminished energy production induced
by mitochondrial dysfunction.
UP-REGULATION OF OxPhos ACTIVITY: TRANSGENIC MICE
Reddy et al. (2004) investigated the up-regulation of mitochon-
drial genes as a compensatory response to impaired energy
metabolism by using an APP transgenic mouse model (the
Tg2576 mouse model). The experimental studies focused on
gene expression profiles at three stages of the disease progres-
sion. The stages considered were 2 month old mice (long before
amyloid pathology), 5 month old mice—immediately before
amyloid pathology, and 18month old mice (after amyloid pathol-
ogy and cognitive impairment). The analysis showed that the
genes which are related to mitochondrial energy metabolism were
up-regulated already in 2-month old mice, preceding the cog-
nitive impairments that will appear later with age. The claim
that this up-regulation is a compensatory response to mitochon-
drial impairment was based on studies of changes in cytochrome
oxidase which was significantly decreased. Additional support
for the hypothesis was based on changes in Complex (I), (III),
and (IV). Complex (III) and (IV) both showed an increase in
mRNA expression in both early and definite AD patients, a change
associated with a great demand on energy production.
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THERAPEUTIC IMPLICATIONS: SUPPRESSING THE INVERSE
WARBURG EFFECT
The metabolic stability theory of aging contends that the increase
in probability of death associated with the aging process is the
result of the cumulative effects of random perturbations on
mitochondrial function (Brink et al., 2008).
These perturbations will ultimately induce metabolic dysregu-
lation in some neurons and result in compensatory up-regulation
of OxPhos—the Inverse-Warburg effect—ultimately contributing
to the pathogenesis of AD. Accordingly, AD is an age-related dis-
ease and the transition toward the various hallmarks of the disease
is a consequence of the aging process.
The model predicts that the transition toward AD is deter-
mined by the intensity of natural selection. Accordingly, impeding
this transition may be modulated by regulating this evolution-
ary force. There are two principal strategies for reducing selection
intensity:
(1) Enhancing the available concentration of oxidizable sub-
strates such as lactate: neurons most likely utilize lactate
as an important energy source under conditions of cellu-
lar stress. Lactate is produced by glycolysis in the astrocytes.
An increase of glycolytic activity in astrocytes will increase
the abundance of the energy source lactate, and thereby
reduce the selective advantage of Type II cells. Alternatively,
ketone bodies can also represent alternative oxidizable sub-
strates for neurons. Enchancing the availability of these
substrates could be achieved by different approaches. For
example:
(a) Pharmacological agents enhancing the activation of
ionotropic glutamate receptors expressed by astrocytes
(e.g., ampakines) have been shown to enhance the gly-
colytic response of astrocytes to glutamatergic activity
(Pellerin and Magistretti, 2005).
(b) The glycolytic phenotype of astrocytes can be enhanced
by pharmacological agents inhibiting proline hydroxy-
lases (e.g., Dimethyloxalylglycine), leading to a stabiliza-
tion of the transcription factor HIF-1α in astrocytes that
activates expression of several key enzymes and trans-
porters involved in glycolysis (Brix et al., 2012; Rosafio
and Pellerin, 2014).
(c) Ketogenic diets. Ketone bodies have been shown to be
adequate alternative oxidative energy substrates for the
brain and to provide beneficial effects in certain patho-
logical conditions that include epilepsy but also neurode-
generative diseases such as Alzheimer’s disease (Gasior
et al., 2006) as well as in preventing cognitive decline
with aging (Balietti et al., 2010). Moreover, astrocytes
have been shown to have the capacity to produce ketone
bodies (Guzman and Blazquez, 2001). Just as endoge-
nously produced lactate, they may alleviate the selective
advantage of Type II neurons.
(2) Modulating the damage due to the collapse of homeostasis in
ROS: both very high and very low concentration of ROS can
have deleterious effects and thereby drive the system toward a
state in which neuronal dysfunction is propagated to nearby
neurons.
(a) The effect of high concentration of ROS: This condition
can be diminished by the upregulation of antioxidant
enzymes, e.g., catalase or superoxide dismutase.
(b) The effect of low concentration of ROS: Cell signaling
is compromised when concentration of ROS is signifi-
cantly reduced. Thus upregulation of antioxidant activ-
ities must be done cautiously to avoid disruption of
oxidant signaling, with a focus on strategies to main-
tain stable levels of ROS rather than to achieve maximal
reduction of ROS levels.
The theory we have developed in this article provides an evolu-
tionary rationale for the possible effectiveness of these therapeutic
strategies, and suggest furthermore how related target enzymes
and/or metabolic pathways may have similar therapeutic effects.
Thus, our hypothesis of the role of the Inverse Warburg effect
in AD leads to testable predictions regarding novel therapeutic
strategies for AD.
The inverse Warburg effect postulates that the up-regulation
of OxPhos activity initiates the neurodegenerative cascade. This
up-regulation of OxPhos has a metabolic origin—mitochondrial
dysregulation induced by the process of aging. The therapeutic
strategies which the metabolic perspective advocate is neuroglial.
These strategies involve methods to enhance glial lactate supply
thereby decreasing the selective advantage of unhealthy neurons.
These features and the diagnostic programs which the two classes
of models describe are summarized in Table 3.
In order to be able to test some of the predictions made
based on the Inverse Warburg hypothesis, it would be quite use-
ful to have access to an appropriate animal model. Since an
enhanced OxPhos activity would be not only a hallmark but
also a causative factor of the process leading to neurodegener-
ation in the context of Alzheimer’s disease, development of a
mouse model exhibiting such a feature would be useful. The per-
oxisome proliferator-activated receptor γ coactivator PGC-1α is
a key component involved in the regulation of mitochondrial
Table 3 | Amyloid cascade hypothesis and the neuroenergetic model.
Properties Amyloid cascade model Inverse Warburg effect
Primary cause Over production of Beta
amyloid
Upregulation of OxPhos
Diagnostic
strategy
Test for beta amyloid Test for increased OxPhos
Therapeutic
strategy
Drugs to reduce
Toxicity of beta
Amyloid
Drugs to
1) Enhance glial
lactate supply
2) Accentuate glial
glycolytic phenotype
3) Control antioxidant
therapy
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biogenesis. Enhancing mitochondrial biogenesis via an overex-
pression of PGC-1α might be a good strategy to obtain an
enhanced OxPhos activity in the central nervous system and par-
ticularly in neurons. Of note, a transgenic mouse overexpressing
PGC-1α in all tissues has already been generated (Liang et al.,
2009). Interestingly, when such mice were crossed with the Tg
19959 transgenic mouse model for Alzheimer’s disease, it wors-
ened the phenotype by causing mitochondrial abnormalities,
exarcerbating amyloid and tau accumulation, inducing neuronal
death as well as provoking behavioral abnormalities (as expected
according to the Inverse Warburg hypothesis) instead of improv-
ing it by enhancing OxPhos activity (as postulated based on the
hypothesis that β-amyloid reduces OxPhos activity) (Dumont
et al., 2014). Such trangenic mice aiming at selectively enhanc-
ing OxPhos activity in neurons could represent excellent models
to test experimentally the validity and usefulness of the Inverse
Warburg hypothesis, especially if examined in the context of
aging.
CONCLUSION
Alzheimer’s disease is a neurodegenerative disorder, character-
ized by neuronal loss and progressive cognitive decline leading
to dementia. This article explains how the up-regulation of
OxPhos acivity in impaired neurons and competition for a lim-
ited resource (astrocyte-derived lactate as a substrate for neuronal
OxPhos) can lead to deleterious effects on initially healthy neu-
rons in the vicinity of other neurons that have mitochondrial
dysfunction. The model predicts that the severity of the disease
will be a consequence of the intensity of natural selection involv-
ing two classes of neurons: Type I neurons, cells with normal
levels of OxPhos activity, and Type II neurons, cells with mito-
chondrial dysfunction and compensatory increases in levels of
OxPhos.
Our analysis predicts that the intensity of selection, which
depends largely on the capacity of astrocytes to supply suffi-
cient amounts of energy substrates, can be reduced by metabolic
interventions that: (a) alter the composition of the neuronal
microenvironment by increasing astrocytic lactate production,
such that lactate is no longer a limiting resource; and (b) reduce
the deleterious effects of large variations in ROS by the cautious
use of antioxidants to modulate the effects of high ROS.
This article has contrasted the amyloid cascade model—a
genetic, neuroncentric depiction of the origin and development
of AD, with a neuroenergetic model—a metabolic, neuron-glial
depiction of AD. The contrast is analyzed in terms of certain
classes of empirical observations which have been observed in
studies of AD. These empirical observations are consistent with
the neuroenergetic model but inconsistent with the amyloid
hypothesis.
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